[CLDX] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -83.35%
YoY- 85.41%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 887 546 715 1,425 1,764 941 2,763 -53.01%
PBT -10,447 -11,413 -11,779 -17,239 -9,402 -7,243 -16,407 -25.92%
Tax -4,448 -5,090 -2,990 5,234 -8,746 -14,912 -15,798 -56.94%
NP -10,447 -11,413 -11,779 -17,239 -9,402 -7,243 -16,407 -25.92%
Tax Rate - - - - - - - -
Total Cost 11,334 11,959 12,494 18,664 11,166 8,184 19,170 -29.48%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin -1,177.79 -2,090.29 -1,647.41 -1,209.75 -532.99 -769.71 -593.81 57.66%
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS -0.64 -0.75 -0.84 -1.40 -0.81 -0.66 -1.67 -47.14%
EPS Diluted -0.64 -0.75 -0.84 -1.40 -0.81 -0.66 -1.67 -47.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.